“Today, medicines work well in only a fraction of a target patient population. Not only is this a disservice to hundreds of thousands of patients, it is also a huge contributing factor to the poor performance and failure of many clinical trials.”

https://www.eyeforpharma.com/philadelphia/webinar

This is going to be an interesting discussion regarding #DigitalClinincalTrials, #DigitalTrials.

---

Discover the algorithms that ‘canvass different datasets‘ to help find the necessary ‘unique patient populations’ with the aim of creating personalised trials.

You can find out how to ‘virtually connect eligible patients for pre-screening’ as well as how to use ‘telemedicine to further reduce on-site screening failures‘.

Learn how to ‘improve trial design, site selection and predict results‘ through using ‘Machine Learning‘ – adjust your inclusion and exclusion criteria accordingly.

Discover the #algorithms that ‘canvass different #datasets’ to help find the necessary ‘unique #patientpopulations’ with the aim of creating #personalisedtrials. @eyeforpharma webinar #digitaltrials

Tweet

---

Panelists include:

---

• Jacob LaPorte | Co-Founder – Novartis BIOME

---

• Mohammed Ali | Global Head Digital Development – Boehringer Ingelheim

---

• Michelle Longmire | CEO – Medable

---

• Adama Ibrahim | Associate Director, POC, Global Clinical Operations – Biogen

---

Moderator: Paul Simms Chairman – eyeforpharma

Sign up now to be part of a very exciting session!

---

---